CXD-101 是一种选择性和具有口服活性的 I 类HDAC抑制剂，有抗肿瘤活性，对HDAC1、HDAC2和HDAC3的IC50分别为 63、570 和 550 nM。

CXD101 is a novel class I-selective HDACi (HDAC1 (IC50 : 63nM), HDAC2 (IC50 :570nM), HDAC3 (IC50 :550nM)). CXD101 has no activity against HDAC class II

934828-12-3

C24H29N5O

403.53

CXD-101

DMSO:31 mg/mL (76.82 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years